0001209191-20-050615.txt : 20200915
0001209191-20-050615.hdr.sgml : 20200915
20200915213753
ACCESSION NUMBER: 0001209191-20-050615
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200911
FILED AS OF DATE: 20200915
DATE AS OF CHANGE: 20200915
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WEST MICHAEL D
CENTRAL INDEX KEY: 0001202529
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38519
FILM NUMBER: 201177284
MAIL ADDRESS:
STREET 1: 1010 ATLANTIC AVENUE, SUITE 102
CITY: ALAMEDA
STATE: CA
ZIP: 94501
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AgeX Therapeutics, Inc.
CENTRAL INDEX KEY: 0001708599
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 821436829
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 965 ATLANTIC AVENUE
STREET 2: SUITE 101
CITY: ALAMEDA
STATE: CA
ZIP: 94501
BUSINESS PHONE: 510-671-8370
MAIL ADDRESS:
STREET 1: 965 ATLANTIC AVENUE
STREET 2: SUITE 101
CITY: ALAMEDA
STATE: CA
ZIP: 94501
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-09-11
0
0001708599
AgeX Therapeutics, Inc.
AGE
0001202529
WEST MICHAEL D
965 ATLANTIC AVENUE, SUITE 101
ALAMEDA
CA
94501
1
1
0
0
Chief Executive Officer
Common Stock, $0.0001 par value
2020-09-11
4
M
0
3125
0.00
A
29635
D
Common Stock, $0.0001 par value
2020-09-11
4
F
0
1081
0.8095
D
28554
D
Restricted Stock Units
0.00
2020-09-11
4
M
0
3125
0.00
D
Common Stock
3125
31250
D
Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4.
Restricted Stock Units vested on September 11, 2020.
/s/Michael D. West
2020-09-15